CVB homepage

Back in October, a mobile cardiac imaging provider and its CEO agreed to pay $85 million to settle allegations they had participated in a kickback scheme. This latest DOJ complaint focuses on a former executive not named in that initial settlement. 

One of the world's leading heart hospitals is seeing significant growth. This represents the first time it has hired four new cardiothoracic surgeons in a single 12-month period. 

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

offender-trouble-handcuffs-police-arrest-2102488.jpg

Detectives believe there may be additional victims of the Texas cardiologist. Former patients with anything to report are being asked to call in and share their stories. 

Francisco Arabia, MD, Banner Health, explains trends in total artificial hearts (TAH) in advanced heart failure patients and what is coming in new technology.

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.

Procyrion's Aortix percutaneous mechanical circulatory support (pMCS) device targets acute decompensated heart failure (ADHF) patients with cardiorenal syndrome (CRS).

Researchers are presently tracking the safety and effectiveness of the new device in patients with ADHF compared to diuretics alone.